Log in to your Inderes Free account to see all free content on this page.
Lipidor
Less than 1K followers
All
Press releases
ShowingAll content types
Lipidor announces today negative results from the company's Phase III clinical study of AKP02G2 for psoriasis
Lipidor announces database lock in its Phase III clinical study of the psoriasis candidate AKP02G2
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio